ETHZilla Corporation Warrant
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATNFW research report →
Companywww.180lifesciences.com
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
- CEO
- Lloyd Blair Jordan
- IPO
- 2017
- Employees
- 4
- HQ
- Palo Alto, DE, US
Price Chart
Valuation
- Market Cap
- $2.60M
- P/E
- -0.17
- P/S
- 6.42
- P/B
- 0.53
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -2622.51%
- Net Margin
- -5489.52%
- ROE
- -240.64%
- ROIC
- -126.21%
Growth & Income
- Revenue
- $6.55M · 0.00%
- Net Income
- $-450,521,000 · 0.00%
- EPS
- $-55.18 · 0.00%
- Op Income
- $-233,450,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.44
- 52W Low
- $0.36
- 50D MA
- $0.03
- 200D MA
- $0.01
- Beta
- 0.41
- Avg Volume
- 404.02K
Get TickerSpark's AI analysis on ATNFW
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 28, 26 | Lomashuk Konstantin | other | 0 |
| Apr 28, 26 | Lomashuk Konstantin | other | 1,555,573 |
| Apr 28, 26 | Lomashuk Konstantin | other | 546,433 |
| Apr 2, 26 | Dalton Angela | other | 203,562 |
| Dec 19, 25 | Dalton Angela | other | 0 |
| Apr 2, 26 | Edwards Michael A | other | 203,562 |
| Apr 2, 26 | SUCKLING ANDREW P | other | 241,918 |
| Apr 2, 26 | Smith Ryan Lewis | other | 241,918 |
| Apr 2, 26 | Saunders John Tazewell | other | 358,592 |
| Apr 2, 26 | Rudisill McAndrew | other | 1,884,979 |
Our ATNFW Coverage
We haven't published any research on ATNFW yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ATNFW Report →